Article
iPSC culture expansion selects against putatively actionable mutations in the mitochondrial genome.
Stem cell reports - 12 Oct 2021
Kosanke Maike, Davenport Colin, Szepes Monika, Wiehlmann Lutz, Kohrn Tim, Dorda Marie, Gruber Jonas, Menge Kaja, Sievert Maike, Melchert Anna, Gruh Ina, Göhring Gudrun, Martin Ulrich
Abstract excerpt
Therapeutic application of induced pluripotent stem cell (iPSC) derivatives requires comprehensive assessment of the integrity of their nuclear and mitochondrial DNA (mtDNA) to exclude oncogenic potential and functional deficits. It is unknown, to which extent mtDNA variants originate from their parental cells or from de novo mutagenesis, and whether dynamics in heteroplasmy levels are caused by inter- and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
